Laparoscopic Surgery for Severe Recto-vaginal Endometriosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Surgery for severe endometriosis.
- Who it may be relevant to
- Registry conditions: Endometriosis Rectovaginal Septum. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Laparoscopic Surgery for Severe Recto-vaginal Endometriosis: A Prospective Cohort Study
Overview
To determine the quality of life following the radical excision of recto-vaginal endometriosis.
Detailed description
Patients undergoing surgery for severe endometriosis with bowel involvement were asked to complete pre-operative and post operative questionnaires at 2, 6 and 12 months, then 5, 10, 15, 20 and 25 years post operatively.
Quality of life measured using the EHP-30 and EQ-5D questionnaires. Bowel symptoms were measured using GIQLI. Dysmenorrhoea, dyspareunia, dyschezia and chronic pain were measured using a visual analogue scale.
Interventions
- Procedure Surgery for severe endometriosis
Consecutive patients undergoing excisional surgery for severe endometriosis with bowel involvement
Primary outcome measures
- Quality of life measured using the Endometriosis Health Profile 30 (EHP-30) and EuroQol-5 dimension (EQ-5D) questionnaires. [Time frame: 1 year post operative]
- Bowel symptoms measured using the Gastro-intestinal Quality of Life Index (GIQLI). [Time frame: 1 year post operative]
- Dysmenorrhoea measured using a visual analogue scale (VAS). [Time frame: 1 year post operative]
- Dyspareunia measured using a visual analogue scale (VAS). [Time frame: 1 year post operative]
- Dyschezia measured using a visual analogue scale (VAS). [Time frame: 1 year post operative]
- Chronic pain measured using a visual analogue scale (VAS). [Time frame: 1 year post operative]
Secondary outcome measures (6)
- Quality of life measured using the EHP-30 and EQ-5D questionnaires. [Time frame: 2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative]
- Bowel symptoms were measured using GIQLI. [Time frame: 2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative]
- Dysmenorrhoea measured using a visual analogue scale. [Time frame: 2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative]
- Dyspareunia measured using a visual analogue scale. [Time frame: 2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative]
- Dyschezia measured using a visual analogue scale. [Time frame: 2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative]
- Chronic pain measured using a visual analogue scale. [Time frame: 2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative]
Eligibility criteria
Inclusion criteria
- All women undergoing planned surgery for severe endometriosis with bowel involvement.
Exclusion criteria
- Patients who declined to complete questionnaires for whatever reason and/or have their anonymous data analysed.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
United Kingdom · 1 center
- Royal Surrey County Hospital NHS Trust — Guildford
Identifiers
NCT: NCT02471443 · 15DEV0009